Oral contraception and congenital malformations in offspring: A review and metaanalysis of the prospective studies

Obstetrics and Gynecology

Volumn 76, Issue 3, 1990, Pages 552-557

  Bracken, Michael B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CONGENITAL MALFORMATION; EMBRYO; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ABNORMALITIES, DRUG-INDUCED; CONTRACEPTIVES, ORAL; HUMAN; META-ANALYSIS; PROSPECTIVE STUDIES; RISK;

EID: 0025151157     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987;9:1–30.
2. Thacker SB. Meta-analysis: A quantitative approach to researchintegration. JAMA 1988;259:1685–9.
3. Yusuf S, Simon R, Ellenberg S, eds. Proceedings of the workshopon methodologic issues in overviews of randomized clinical trials, May 1986. Stat Med 1987;6.
4. Glass GV, McGraw B, Smith ML. Meta-analysis in social research. Beverly Hills, California: Sage, 1981.
5. Light RJ, Pillemer DB. Summing up: The science of reviewing research. Cambridge, Massachusetts: Harvard University Press,1984.
6. Shapiro S, Slone D. The effects of exogenous female hormones onthe fetus. Epidemiol Rev 1979;1:110–22.
7. Wilson JA, Brent RL. Are female sex hormones teratogenic? AmJ Obstet Gynecol 1981;141:567–80.
8. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987;316:450–5.
9. Bracken MB. Methodologic issues in the epidemiologic investiga-tion of drug-induced congenital malformations. In: Bracken MB, ed. Perinatal epidemiology. New York: Oxford University Press,1984.
10. Werler MM, Pober BR, Nelson K, Holmes LB. Reporting accuracyamong mothers of malformed and nonmalformed infants. Am J Epidemiol 1989;129:415–21.
11. Mitchell AA, Cottier LB, Shapiro S. Effect of questionnaire designon recall of drug exposure in pregnancy. Am J Epidemiol 1986;123:670–6.
12. Garratini S, Berendes HW, eds. Pharmacology of steroid contra-ceptive drugs. New York: Raven Press, 1977.
13. Rothman KJ, Boice JD. Epidemiologic analysis with a program-mable calculator. NIH publication no. 79–1649. Washington, DC:National Institutes of Health, 1979.
14. Rothman KJ. Modern epidemiology. Boston: Little, Brown & Co, 1986:195.
15. Greenland S, Robins JM. Estimation of a common effect param-eter from sparse follow-up data. Biometrics 1985;41:55–68.
16. Peterson WF. Pregnancy following oral contraceptive therapy. Obstet Gynecol 1969;34:363–7.
17. Robinson SC. Pregnancy outcome following oral contraceptives. Am J Obstet Gynecol 1971;109:354–8.
18. Haller J. Hormontherapie wahrend der graviditat. DeutschesArzteblatt 1974;4:1013–5.
19. Oechsli FW. Studies of the consequences of contraceptive failure. Final report for contract ND1–HD–5–2816. University of Califor-nia, Berkeley: School of Public Health, 1976.
20. Royal College of General Practitioners. Oral contraception study: The outcome of pregnancy in former oral contraceptive users. Br J Obstet Gynaecol 1976;83:606–16.
21. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs inpregnancy. Littleton, Massachusetts: Publishing Sciences Group, 1977.
22. Rothman KJ, Louik C. Oral contraceptives and birth defects. N Engl J Med 1978;299:522–4.
23. Vessey M, Meisler L, Flavel R, Yeates D. Outcome of pregnancyin women using different methods of contraception. Br J Obstet Gynaecol 1979;86:548–56.
24. Kasan PN, Andrews J. Oral contraception and congenital abnor-malities. Br J Obstet Gynaecol 1980;87:545–51.
25. Harlap S, Eldor J. Births following oral contraceptive failures. Obstet Gynecol 1980;55:447–52.
26. Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. Lack of association between contraceptive usage and congenital malformations in offspring. Am J Obstet Gynecol 1983;147:923–8.
27. Harlap S, Shiono PH, Ramcharan S. Congenital abnormalities in the offspring of women who used oral and other contraceptives around the time of conception. Int J Fertil 1985;30:39–47.
28. Poland BJ. The influence of recent use of an oral contraceptive on early intrauterine development. Am J Obstet Gynecol 1973; 116:1138–42.
29. Carr DH. Chromosome studies in selected spontaneous abortions: 1. Conception after oral contraceptives. Can Med Assoc J 1970;103:343–8.
30. Begg CB, Berlin JA. Publication bias: A problem in interpreting medical data. J R Stat Soc 1988;151:419–45.
31. Bracken MB, Holford TR, White C, Kelsey JK. Role of oral contraception in congenital malformations of offspring. Int J Epidemiol 1978;7:309–17.
32. Greenberg G, Inman WH, Weatherall JA, Adelstein AM, Haskey JC. Maternal drug histories and congenital abnormalities. Br Med J [Clin Res] 1977;2:853–6.
33. Janerich DJ, Piper JM, Glebatis DM. Oral contraceptives and birth defects. Am J Epidemiol 1980;112:73–9.
34. Lammer EJ, Cordero JF. Exogenous sex hormone exposure and the risk for major malformations. JAMA 1986;255:3128–32.
35. Savolainen E, Saksela E, Saxen L. Teratogenic hazards of oral contraceptives analyzed in a national malformation register. Am J Obstet Gynecol 1981;140:521–4.
36. Nora JJ, Nora AH, Blu J, et al. Exogenous progestogen and estrogen implicated in birth defects. JAMA 1978;240:837–43.
37. Yasuda M, Miller JR. Prenatal exposure to oral contraceptives and transposition of the great vessels in man. Teratology 1975;12: 239–43.
38. Janerich DT, Piper JM, Glebatis DM. Oral contraceptives and congenital limb reduction defects. N Engl J Med 1974;291:697–700.
39. Kricker A, Elliott JW, Forrest JM, McCredie J. Congenital limb reduction deformities and use of oral contraceptives. Am J Obstet Gynecol 1986;155:1072–8.
40. Czeizel A, Keller S, Bod M. An etiological evaluation of the increased occurrence of congenital limb reduction abnormalities in Hungary, 1975–1978. Int J Epidemiol 1983;12:445–9.
41. Mackenzie SG, Lippman A. An investigation of report bias in a case-control study of pregnancy outcome. Am J Epidemiol 1989; 129:65–75.